{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:10:45Z","timestamp":1792426245468,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2023,11,23]]},"DOI":"10.1038\/s41416-023-02460-2","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T19:02:30Z","timestamp":1696878150000},"page":"1766-1772","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy"],"prefix":"10.1038","volume":"129","author":[{"given":"Constance","family":"d\u2019Abrigeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2272-3678","authenticated-orcid":false,"given":"Mair\u00e9ad G.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Le Sourd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lamarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-717X","authenticated-orcid":false,"given":"Astrid","family":"Li\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lo\u00efse","family":"Bourien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Peinoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Uguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Hubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1999-0863","authenticated-orcid":false,"given":"Juan W.","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-7741","authenticated-orcid":false,"given":"Julien","family":"Edeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"2460_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.6004\/jnccn.2009.0030","volume":"7","author":"KY Chang","year":"2009","unstructured":"Chang KY, Chang JY, Yen Y. Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. J Natl Compr Cancer Netw JNCCN. 2009;7:423\u20137.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"2460_CR2","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.ejca.2015.05.018","volume":"51","author":"A Lamarca","year":"2015","unstructured":"Lamarca A, Benafif S, Ross P, Bridgewater J, Valle JW. Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: effective intervention in patients with luminal disease. Eur J Cancer. 2015;51:1694\u2013703.","journal-title":"Eur J Cancer"},{"key":"2460_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","volume":"76","author":"L Izquierdo-Sanchez","year":"2022","unstructured":"Izquierdo-Sanchez L, Lamarca A, La Casta A, Buettner S, Utpatel K, Kl\u00fcmpen HJ, et al. Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. J Hepatol. 2022;76:1109\u201321.","journal-title":"J Hepatol"},{"key":"2460_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2184.2005.00354.x","volume":"38","author":"MR Alison","year":"2005","unstructured":"Alison MR, Lovell MJ. Liver cancer: the role of stem cells. Cell Prolif. 2005;38:407\u201321.","journal-title":"Cell Prolif"},{"key":"2460_CR5","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1038\/sj.onc.1209558","volume":"25","author":"T Roskams","year":"2006","unstructured":"Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene. 2006;25:3818\u201322.","journal-title":"Oncogene"},{"key":"2460_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Hepatol. 2020;72:95\u2013103.","journal-title":"J Hepatol"},{"key":"2460_CR7","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/hep.32007","volume":"74","author":"YT Lee","year":"2021","unstructured":"Lee YT, Wang JJ, Luu M, Noureddin M, Nissen NN, Patel TC, et al. Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the United States. Hepatol Balt Md. 2021;74:2622\u201332.","journal-title":"Hepatol Balt Md"},{"key":"2460_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/MEG.0000000000001036","volume":"30","author":"D Jesper","year":"2018","unstructured":"Jesper D, Heyn SG, Schellhaas B, Pfeifer L, Goertz RS, Zopf S, et al. Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma: a retrospective analysis of 156 cases in a single center. Eur J Gastroenterol Hepatol. 2018;30:552\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2460_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1440-1746.2003.02977.x","volume":"18","author":"CK Hui","year":"2003","unstructured":"Hui CK, Yuen MF, Tso WK, Ng IOL, Chan AOO, Lai CL. Cholangiocarcinoma in liver cirrhosis. J Gastroenterol Hepatol. 2003;18:337\u201341.","journal-title":"J Gastroenterol Hepatol"},{"key":"2460_CR10","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.5754\/hge11126","volume":"58","author":"YY Li","year":"2011","unstructured":"Li YY, Chen DJ, Li XR, Tian BN, Liu WD, Liu G, et al. Clinicopathological characteristics of intrahepatic cholangiocarcinoma in patients with cirrhosis. Hepatogastroenterology. 2011;58:1787\u201390.","journal-title":"Hepatogastroenterology"},{"key":"2460_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s11605-011-1419-8","volume":"15","author":"YY Li","year":"2011","unstructured":"Li YY, Li H, Lv P, Liu G, Li XR, Tian BN, et al. Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment. J Gastrointest Surg J Soc Surg Aliment Trac. 2011;15:608\u201313.","journal-title":"J Gastrointest Surg J Soc Surg Aliment Trac"},{"key":"2460_CR12","doi-asserted-by":"publisher","first-page":"6543423","DOI":"10.1155\/2017\/6543423","volume":"2017","author":"S Jeong","year":"2017","unstructured":"Jeong S, Gao L, Tong Y, Xia L, Xu N, Sha M, et al. Prognostic impact of cirrhosis in patients with intrahepatic cholangiocarcinoma following hepatic resection. Can J Gastroenterol Hepatol. 2017;2017:6543423.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2460_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u2014the ALBI grade. J Clin Oncol. 2015;33:550\u20138.","journal-title":"J Clin Oncol"},{"key":"2460_CR14","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41416-021-01535-2","volume":"125","author":"A Childs","year":"2021","unstructured":"Childs A, Zakeri N, Ma YT, O\u2019Rourke J, Ross P, Hashem E, et al. Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit. Br J Cancer. 2021;125:1350\u20135.","journal-title":"Br J Cancer"},{"key":"2460_CR15","doi-asserted-by":"publisher","first-page":"100324","DOI":"10.1016\/j.lanepe.2022.100324","volume":"15","author":"C Neuzillet","year":"2022","unstructured":"Neuzillet C, Emery C, Teissier C, Bou\u00e9e S, Li\u00e8vre A. Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: a nationwide retrospective analysis. Lancet Reg Health - Eur. 2022;15:100324.","journal-title":"Lancet Reg Health - Eur"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02460-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02460-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02460-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T08:04:26Z","timestamp":1700726666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02460-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,23]]}},"alternative-id":["2460"],"URL":"https:\/\/doi.org\/10.1038\/s41416-023-02460-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"2 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}